COMPLEMENT C3

Product definition

Mixture

CLP CLASSIFICATION

This product has been evaluated per the classification criteria in Regulation (EC) No 1272/2008 (CLP) and the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). This product does not meet the criteria for classification in accordance with either CLP or GHS. -

EU Classification

Directive 67/548/EEC or Directive 1999/45/EC -

Classification system

The classification is in alignment with current European regulations.

2.2 Label elements

Labelling according to Regulation (EC) No 1272/2008(CLP): None -

Hazard pictograms

None -

Signal word

None -

Hazard statements

None -

Additional information

Refer to section 15 for labelling per Directives 67/548/EEC or 1999/45/EC - Labelling according to Directives 67/548/EEC or 1999/45/EC

Hazardous Ingredients

None -

Principle Routes of Exposure

Skin: No adverse effects expected when used as directed. Eye: No adverse effects expected when used as directed. Inhalation: No adverse effects expected when used as directed. Ingestion: No adverse effects expected when used as directed. NOTE: All blood products should be treated as potentially infectious. Source material from which this product was derived was found negative when tested in accordance with current FDA required tests. No known test methods can offer assurance that products derived from human blood will not transmit infectious agents. Emergency Phone Number: In emergency situation please contact the National Poison Solidarity Center (Turkey) for information in Turkish :( 114) (24 hours/7 days). Please contact with Archem for information in English +(90) 212 444 0 892 (Turkey) (8 30-18 30/ except Sundays)

2.3 Other hazards

None -

PBT Substances

Not applicable -

vPvB Substances

Not applicable